AVLN vs MLTX: stock comparison and AI forecast
Avalyn Pharma Inc. (AVLN) and Moonlake Immunotherapeutics (MLTX) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
AVLN Avalyn Pharma Inc.
- Market Cap
- $1.14B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
- NO CURRENT FORECAST
MLTX Moonlake Immunotherapeutics
- Market Cap
- $1.07B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
- NO CURRENT FORECAST
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- AVLN and MLTX have similar market capitalizations ($1.14B and $1.07B).
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | AVLN | MLTX |
|---|---|---|
| Market Cap | $1.14B | $1.07B |
| P/B Ratio | 2.85x | – |
| EPS | – | $-3.50 |
| Book Value/Share | $8.99 | – |
| FCF/Share | – | $-2.65 |
Profitability & Margins
| Metric | AVLN | MLTX |
|---|---|---|
| Tax Rate | – | -0.4% |
Financial Health
| Metric | AVLN | MLTX |
|---|---|---|
| Current Ratio | 33.12x | 12.56x |
| D/E Ratio | 0.07x | – |
| Financial Leverage | 1.07x | – |
| Interest Coverage | – | -28.9x |
| Working Capital | $347M | $525M |
Cash Flow
| Metric | AVLN | MLTX |
|---|---|---|
| Operating Cash Flow | – | -$225M |
| Free Cash Flow | – | -$225M |
| Capital Spending | – | $0.00M |
Income Statement
| Metric | AVLN | MLTX |
|---|---|---|
| Operating Income | – | -$268M |
| R&D Expense | – | $221M |
Dividend & Shareholder Information
| Metric | AVLN | MLTX |
|---|---|---|
| Shares Outstanding | 44M | 85M |
AVLN vs MLTX: stock comparison and AI forecast
Which is bigger, AVLN or MLTX?
AVLN and MLTX have similar market capitalizations ($1.14B and $1.07B).
Which one does Intratio's AI model rank higher, AVLN or MLTX?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.